Awarded
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Axitinib, ATC L01EK01 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)
- Contract value
- no value published
- Bids received
- 5
- Published
- 2 Jul 2026
- Awarded
- 1 Sept 2025
- Contract start
- 1 Sept 2025
- Contract end
- 1 Sept 2027estimated
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|
| 356 - BARMER - Mometason - R01AD09 | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hexal 1A Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |
| 355 - BARMER - Bupropion - N06AX12 | DAK-Gesundheit | Accord Healthcare GmbH, Basics GmbH, BG Hexal 1A Pharma GbR | — | 6 Aug 2026 |
| 354 - BARMER - Escitalopram - N06AB10 (FTA / SMT) | DAK-Gesundheit | BG Hexal 1A Pharma GbR, Micro Labs GmbH, PUREN Pharma GmbH & Co. KG | — | 6 Aug 2026 |
| 353 - BARMER - Levetiracetam - N03AX14 (FTA) | DAK-Gesundheit | Accord Healthcare S.L.U. vertreten durch Accord Healthcare GmbH, betapharm Arzneimittel GmbH, PUREN Pharma GmbH & Co. KG | — | 6 Aug 2026 |
| 352 - BARMER - Fentanyl - N02AB03 (PFT) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Hennig/Viatris/Puren GbR, BG Zentiva/Hexal/Aristo GbR | — | 6 Aug 2026 |
| 351 - BARMER - Morphin - N02AA01 (Oral retardiert) | DAK-Gesundheit | BG ALIUD / STADAPHARM GbR, BG Heumann / G.L. Pharma GbR, BG TEVA ratiopharm GbR | — | 6 Aug 2026 |